Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. E-pub ahead of print

    Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

    Sørensen, A. L., Mikkelsen, S. U., Knudsen, T. A., Bjørn, M. E., Andersen, C. L., Bjerrum, O. W., Brochmann, N., Patel, D. A., Gjerdrum, L. M. R., El Fassi, D., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Ellervik, C., Pallisgaard, N., Thomassen, M., Kjær, L., Skov, V. & Hasselbalch, H. C., 2020, In : Haematologica.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2019
  4. Published
  5. Published
  6. 2017
  7. Published

    Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase

    Damgaard, D., Bjørn, M. E., Jensen, P. Ø. & Nielsen, C. H., Dec 2017, In : Journal of Enzyme Inhibition and Medicinal Chemistry. 32, 1, p. 1203-1208 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published
  9. 2016
  10. Published

    Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase

    Damgaard, D., Bjørn, M. E., Steffensen, M. A., Pruijn, G. J. M. & Nielsen, C. H., 5 May 2016, In : Arthritis Research and Therapy. 18, 1, p. 102

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients

    Bjørn, M. E., Holmström, M. O. & Hasselbalch, H. C., 2016, In : Leukemia and Lymphoma. 57, 1, p. 125-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 49908973